109
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Comment on ‘‘how does omalizumab affect the immunoinflammatory response in patients with chronic spontaneous urticaria?’’: reply from author

&
Page 73 | Received 18 Dec 2019, Accepted 20 Dec 2019, Published online: 12 Jan 2020
 

Abstract

We read Cosansu's commentary entitled ‘’Hematological parameters in patients with chronic spontaneous urticaria’’ to our study with a great interest. The author noted that monocytes increased in inflammatory diseases such as urticaria but decreased after treatment. She argued that NMR was not used as an inflammatory marker in previous studies, so that NMR should not be used to evaluate the response to omalizumab treatment in urticaria and decreased by chance. We thank the author for her interest in our article.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.